{"id":36628,"date":"2015-08-31T08:33:47","date_gmt":"2015-08-31T12:33:47","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36628"},"modified":"2015-08-31T08:33:47","modified_gmt":"2015-08-31T12:33:47","slug":"plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628","title":{"rendered":"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Plandai Biotechnology Inc (OTCMKTS:PLPL)<\/strong> and <strong>Generex Biotechnology Corporation (OTCMKTS:GNBT)<\/strong> are the two OTC traded stocks that have been the center of attraction after they issued promising PRs. Plandai <a href=\"https:\/\/finance.yahoo.com\/news\/plandai-biotechnology-inc-announces-expansion-130000276.html\">reported<\/a> an amendment to its preciously finalized deal with USN Worldwide. Under the new amended deal with USN, it will now expand its Phytofare\u00ae sales to USN and associated contract manufacturer firms to the European Union.<\/p>\n<p style=\"text-align: justify;\">Callum Cottrell-Duffield of Planda\u00ed said that they are extremely delighted to expand contract with USN into the EU market. Clearly, it is a big opportunity for the company, as they believe the entry into the European market will increase Phytofare\u00ae catechin ingredient sales. As a pioneer in wellness and sports nutrition, USN knows the advantages of phyto-availability within existing product line-up.<\/p>\n<p style=\"text-align: justify;\"><strong>The buzz<\/strong><\/p>\n<p style=\"text-align: justify;\">Coming to the announcement of Generex, the company <a href=\"the%20sales%20of%20our\">updated<\/a> its stockholders on the development progress of Generex Oral-lyn\u2122. It issued a white paper highlighting the status of Generex Oral-lyn\u2122 and presented at its annual meeting of stockholders. The white paper demonstrates the success of Generex&#8217;s initial attempts to enhance Generex Oral-lyn\u2122 by increasing insulin concentrations. Generex Oral-lyn\u2122 is the company&#8217;s patented buccal insulin spray product.<\/p>\n<p style=\"text-align: justify;\">The white paper explains Generex\u2019s leading efforts in the design and formulation of an alternative way for insulin delivery into the human body that will enable diabetic patients to avoid the inconvenience and discomfort of injections whilst enhancing and preserving the metabolic impact of the dosed insulin.<\/p>\n<p style=\"text-align: justify;\"><strong>The focus<\/strong><\/p>\n<p style=\"text-align: justify;\">Highlighting the major biotech, Bernstein\u2019s Vincent Chen and Geoffrey Porges <a href=\"http:\/\/blogs.barrons.com\/stockstowatchtoday\/2015\/08\/28\/gilead-amgen-account-for-nearly-75-of-the-biotech-profit-pool\/?mod=yahoobarrons&amp;ru=yahoo\">stated<\/a> that<strong> Gilead Sciences, Inc. (NASDAQ:GILD) <\/strong>and <strong>Amgen, Inc. (NASDAQ:AMGN)<\/strong> accounts for 71% of the total biotech market profit pool. However, it is only Gilead that is giving above-average return on capital. As of FY2014, Amgen and Gilead combined comprised for 71% of total industry profits, with <strong>Celgene Corporation (NASDAQ:CELG)<\/strong>, <strong>Biogen Inc (NASDAQ:BIIB)<\/strong>, <strong>Regeneron Pharmaceuticals Inc (NASDAQ:REGN) <\/strong>and <strong>Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)<\/strong> accounting for 10%, 12%, 5% and 3% of the total profit pool, respectively.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Plandai Biotechnology Inc (OTCMKTS:PLPL) and Generex Biotechnology Corporation (OTCMKTS:GNBT) are the two OTC traded stocks that have been the center of attraction after they issued [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":36629,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[11608,11383,11611,2860,11610,4554,4499,2861,4507,4555,4319,4717,4318,7251,4506],"stock_ticker":[],"class_list":["post-36628","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-biogen-inc","tag-biogen-inc-nasdaqbiib","tag-celgene-corporation","tag-celgene-corporation-nasdaqcelg","tag-generex-biotechnology-corporation","tag-generex-biotechnology-corporation-otcmktsgnbt","tag-nasdaqbiib","tag-nasdaqcelg","tag-nasdaqregn","tag-otcmktsgnbt","tag-otcmktsplpl","tag-plandai-biotechnology-inc","tag-plandai-biotechnology-inc-otcmktsplpl","tag-regeneron-pharmaceuticals-inc","tag-regeneron-pharmaceuticals-inc-nasdaqregn","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Plandai Biotechnology Inc (OTCMKTS:PLPL) and Generex Biotechnology Corporation (OTCMKTS:GNBT) are the two OTC traded stocks that have been the center of attraction after they issued [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-08-31T12:33:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png\" \/>\n\t<meta property=\"og:image:width\" content=\"220\" \/>\n\t<meta property=\"og:image:height\" content=\"229\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs\",\"datePublished\":\"2015-08-31T12:33:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628\"},\"wordCount\":344,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png\",\"keywords\":[\"Biogen Inc\",\"Biogen Inc (NASDAQ:BIIB)\",\"Celgene Corporation\",\"Celgene Corporation (NASDAQ:CELG)\",\"Generex Biotechnology Corporation\",\"Generex Biotechnology Corporation (OTCMKTS:GNBT)\",\"NASDAQ:BIIB\",\"NASDAQ:CELG\",\"NASDAQ:REGN\",\"OTCMKTS:GNBT\",\"OTCMKTS:PLPL\",\"Plandai Biotechnology Inc\",\"Plandai Biotechnology Inc (OTCMKTS:PLPL)\",\"Regeneron Pharmaceuticals Inc\",\"Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628\",\"name\":\"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png\",\"datePublished\":\"2015-08-31T12:33:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png\",\"width\":220,\"height\":229},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628","og_locale":"en_US","og_type":"article","og_title":"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs - Wall Street PR","og_description":"Plandai Biotechnology Inc (OTCMKTS:PLPL) and Generex Biotechnology Corporation (OTCMKTS:GNBT) are the two OTC traded stocks that have been the center of attraction after they issued [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-08-31T12:33:47+00:00","og_image":[{"width":220,"height":229,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png","type":"image\/png"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs","datePublished":"2015-08-31T12:33:47+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628"},"wordCount":344,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png","keywords":["Biogen Inc","Biogen Inc (NASDAQ:BIIB)","Celgene Corporation","Celgene Corporation (NASDAQ:CELG)","Generex Biotechnology Corporation","Generex Biotechnology Corporation (OTCMKTS:GNBT)","NASDAQ:BIIB","NASDAQ:CELG","NASDAQ:REGN","OTCMKTS:GNBT","OTCMKTS:PLPL","Plandai Biotechnology Inc","Plandai Biotechnology Inc (OTCMKTS:PLPL)","Regeneron Pharmaceuticals Inc","Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628","url":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628","name":"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png","datePublished":"2015-08-31T12:33:47+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/08\/Generex-Biotechnology-Corporation.png","width":220,"height":229},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plandai-biotechnology-inc-otcmktsplpl-and-generex-biotechnology-corporation-otcmktsgnbt-issues-promising-prs-36628#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Plandai Biotechnology Inc (OTCMKTS:PLPL) And Generex Biotechnology Corporation (OTCMKTS:GNBT) Issues Promising PRs"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36628"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36628\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/36629"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36628"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}